Read More

Why Adverum Biotechnologies Stock Is Trading Higher

Adverum will sell the shares at a price per share of $1.20, representing a premium of approximately 20% to its stock's 30-day volume-weighted average price, and the financing is expected to close on Feb. 8. Adverum anticipates the gross proceeds from the private placement to be approximately $127.5 million, before deducting any offering related expenses and are expected to be sufficient to fund the current operating plan into late 2025.

ADVM

Read More

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

ATRA

Read More

This Analyst With 87% Accuracy Rate Sees Around 11% Upside In Meta Platforms – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

U.S. stocks closed higher on Friday, with the S&P 500 index hitting a new record high during the session. For the week, the S&P 500 gained 1.4%, recording gains for the fourth week in a row.

ALGM